Angiopoietin-like 4 modifies the interactions between lipoprotein lipase and its endothelial cell transporter GPIHBP1

Journal of Biological Chemistry

Volumn 290, Issue 19, 2015, Pages 11865-11877

  Chi, Xun ^a   Shetty, Shwetha K ^a   Shows, Hannah W ^a   Hjelmaas, Alexander J ^a   Malcolm, Emily K ^a   Davies, Brandon S J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELLS; ENZYMES; FATTY ACIDS; LIPOPROTEINS; VEGETABLE OILS;

BINDING PROTEINS; CAPILLARY ENDOTHELIAL CELLS; COILED-COIL DOMAINS; GLYCOSYLPHOSPHATIDYLINOSITOL; HIGH DENSITY LIPOPROTEIN; INHIBITORY ACTIVITY; LIPOPROTEIN LIPASE; PLASMA TRIGLYCERIDES;

CYTOLOGY;

ANGIOPOIETIN LIKE 4 PROTEIN; CARRIER PROTEINS AND BINDING PROTEINS; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED HIGH DENSITY LIPOPROTEIN BINDNG PROTEIN 1; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LIPOPROTEIN LIPASE; UNCLASSIFIED DRUG; ANGIOPOIETIN; ANGPTL4 PROTEIN, HUMAN; CULTURE MEDIUM; GPIHBP1 PROTEIN, HUMAN; LIPOPROTEIN RECEPTOR; PROTEIN BINDING; TRIACYLGLYCEROL;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; SURFACE PROPERTY; ANIMAL; CELL CULTURE; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; GENE EXPRESSION REGULATION; HEK293 CELL LINE; HUMAN; LIPOLYSIS; METABOLISM; PROTEIN TERTIARY STRUCTURE; TRANSPORT AT THE CELLULAR LEVEL;

ANGIOPOIETINS; ANIMALS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; LIPOLYSIS; LIPOPROTEIN LIPASE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, LIPOPROTEIN; TRIGLYCERIDES;

EID: 84929011624     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.623769     Document Type: Article

References (50)

1. Reina, M., Brunzell, J. D., and Deeb, S. S. (1992) Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes. J. Lipid Res. 33, 1823-1832
2. Taylor, K. G., Galton, D. J., and Holdsworth, G. (1979) Insulin-independent diabetes: a defect in the activity of lipoprotein lipase in adipose tissue. Diabetologia. 16, 313-317
3. Kroupa, O., Vorrsjö, E., Stienstra, R., Mattijssen, F., Nilsson, S. K., Sukonina, V., Kersten, S., Olivecrona, G., and Olivecrona, T. (2012) Linking nutritional regulation of Angptl4, Gpihbp1, and Lmf1 to lipoprotein lipase activity in rodent adipose tissue. BMC Physiol. 12, 13
4. Mitrou, P., Boutati, E., Lambadiari, V., Maratou, E., Komesidou, V., Papakonstantinou, A., Sidossis, L., Tountas, N., Katsilambros, N., Economopoulos, T., Raptis, S. A., and Dimitriadis, G. (2010) Rates of lipid fluxes in adipose tissue in vivo after a mixed meal in morbid obesity. Int. J. Obes. 34, 770-774
5. Wang, Y., Puthanveetil, P., Wang, F., Kim, M. S., Abrahani, A., and Rodrigues, B. (2011) Severity of diabetes governs vascular lipoprotein lipase by affecting enzyme dimerization and disassembly. Diabetes 60, 2041-2050
6. Wang, H., and Eckel, R. H. (2009) Lipoprotein lipase: from gene to obesity. Am. J. Physiol. Endocrinol. Metab. 297, E271-E288
7. Olivecrona, T., and Olivecrona, G. (2009) in Cellular Lipid Metabolism (Ehnholm, C., ed) pp. 315-369, Springer, Berlin
8. Davies, B. S., Beigneux, A. P., Fong, L. G., and Young, S. G. (2012) New wrinkles in lipoprotein lipase biology. Curr. Opin. Lipidol. 23, 35-42
9. Davies, B. S., Beigneux, A. P., Barnes, R. H., 2nd, Tu, Y., Gin, P., Weinstein, M. M., Nobumori, C., Nyrén, R., Goldberg, I., Olivecrona, G., Bensadoun, A., Young, S. G., and Fong, L. G. (2010) GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. Cell Metab. 12, 42-52
10. Beigneux, A. P., Davies, B. S., Gin, P., Weinstein, M. M., Farber, E., Qiao, X., Peale, F., Bunting, S., Walzem, R. L., Wong, J. S., Blaner, W. S., Ding, Z.-M., Melford, K., Wongsiriroj, N., Shu, X., et al. (2007) Glycosylphos-phatidylinositol-anchored high density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab. 5, 279-291
11. Davies, B. S., Goulbourne, C. N., Barnes, R. H., 2nd, Turlo, K. A., Gin, P., Vaughan, S., Vaux, D. J., Bensadoun, A., Beigneux, A. P., Fong, L. G., and Young, S. G. (2012) Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells. J. Lipid Res. 53, 2690-2697
12. Beigneux, A. P., Franssen, R., Bensadoun, A., Gin, P., Melford, K., Peter, J., Walzem, R. L., Weinstein, M. M., Davies, B. S., Kuivenhoven, J. A., Kastelein, J. J., Fong, L. G., Dallinga-Thie, G. M., and Young, S. G. (2009) Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase. Arterioscler. Thromb. Vasc. Biol. 29, 956-962
13. Olivecrona, G., Ehrenborg, E., Semb, H., Makoveichuk, E., Lindberg, A., Hayden, M. R., Gin, P., Davies, B. S., Weinstein, M. M., Fong, L. G., Beigneux, A. P., Young, S. G., Olivecrona, T., and Hernell, O. (2010) Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia. J. Lipid Res. 51, 1535-1545
14. Franssen, R., Young, S. G., Peelman, F., Hertecant, J., Sierts, J. A., Schimmel, A. W., Bensadoun, A., Kastelein, J. J., Fong, L. G., Dallinga-Thie, G. M., and Beigneux, A. P. (2010) Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects. Circ. Cardiovasc. Genet. 3, 169-178
15. Coca-Prieto, I., Kroupa, O., Gonzalez-Santos, P., Magne, J., Olivecrona, G., Ehrenborg, E., and Valdivielso, P. (2011) Childhood-onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation. J. Intern. Med. 270, 224-228
16. Charrière, S., Peretti, N., Bernard, S., Di Filippo, M., Sassolas, A., Merlin, M., Delay, M., Debard, C., Lefai, E., Lachaux, A., Moulin, P., and Marçais, C. (2011) GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia. J. Clin. Endocrinol. Metab. 96, E1675-E1679
17. Rios, J. J., Shastry, S., Jasso, J., Hauser, N., Garg, A., Bensadoun, A., Cohen, J. C., and Hobbs, H. H. (2012) Deletion of GPIHBP1 causing severe chylomicronemia. J. Inherit. Metab. Dis. 35, 531-540
18. Weinstein, M. M., Tu, Y., Beigneux, A. P., Davies, B. S., Gin, P., Voss, C., Walzem, R. L., Reue, K., Tontonoz, P., Bensadoun, A., Fong, L. G., and Young, S. G. (2010) Cholesterol intake modulates plasma triglyceride levels in glycosylphosphatidylinositol HDL-binding protein 1-deficient mice. Arterioscler. Thromb. Vasc. Biol. 30, 2106-2113
19. Kersten, S. (2014) Physiological regulation of lipoprotein lipase. Biochim. Biophys. Acta 1841, 919-933
20. Kersten, S., Mandard, S., Tan, N. S., Escher, P., Metzger, D., Chambon, P., Gonzalez, F. J., Desvergne, B., and Wahli, W. (2000) Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J. Biol. Chem. 275, 28488-28493
21. Köster, A., Chao, Y. B., Mosior, M., Ford, A., Gonzalez-DeWhitt, P. A., Hale, J. E., Li, D., Qiu, Y., Fraser, C. C., Yang, D. D., Heuer, J. G., Jaskunas, S. R., and Eacho, P. (2005) Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 146, 4943-4950
22. Sukonina, V., Lookene, A., Olivecrona, T., and Olivecrona, G. (2006) Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc. Natl. Acad. Sci. U.S.A. 103, 17450-17455
23. Yoon, J. C., Chickering, T. W., Rosen, E. D., Dussault, B., Qin, Y., Soukas, A., Friedman, J. M., Holmes, W. E., and Spiegelman, B. M. (2000) Peroxisome proliferator-activated receptor γ target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol. Cell. Biol. 20, 5343-5349
24. Dijk, W., and Kersten, S. (2014) Regulation of lipoprotein lipase by Angptl4. Trends Endocrinol. Metab. 25, 146-155
25. Goulbourne, C. N., Gin, P., Tatar, A., Nobumori, C., Hoenger, A., Jiang, H., Grovenor, C. R., Adeyo, O., Esko, J. D., Goldberg, I. J., Reue, K., Tontonoz, P., Bensadoun, A., Beigneux, A. P., Young, S. G., and Fong, L. G. (2014) The GPIHBP1-LPL complex is responsible for the margination of triglyceride-rich lipoproteins in capillaries. Cell Metab. 19, 849-860
26. Davies, B. S., Waki, H., Beigneux, A. P., Farber, E., Weinstein, M. M., Wilpitz, D. C., Tai, L.-J., Evans, R. M., Fong, L. G., Tontonoz, P., and Young, S. G. (2008) The expression of GPIHBP1, an endothelial cell binding site for lipoprotein lipase and chylomicrons, is induced by peroxisome proliferator-activated receptor-γ. Mol. Endocrinol. 22, 2496-2504
27. Ben-Zeev, O., Mao, H. Z., and Doolittle, M. H. (2002) Maturation of lipoprotein lipase in the endoplasmic reticulum concurrent formation of functional dimers and inactive aggregates. J. Biol. Chem. 277, 10727-10738
28. Beigneux, A. P., Gin, P., Davies, B. S., Weinstein, M. M., Bensadoun, A., Fong, L. G., and Young, S. G. (2009) Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipase. J. Biol. Chem. 284, 30240-30247
29. Basu, D., Manjur, J., and Jin, W. (2011) Determination of lipoprotein lipase activity using a novel fluorescent lipase assay. J. Lipid Res. 52, 826-832
30. Bergö, M., Olivecrona, G., and Olivecrona, T. (1996) Forms of lipoprotein lipase in rat tissues: in adipose tissue the proportion of inactive lipase increases on fasting. Biochem. J. 313, 893-898
31. Gin, P., Beigneux, A. P., Voss, C., Davies, B. S., Beckstead, J. A., Ryan, R. O., Bensadoun, A., Fong, L. G., and Young, S. G. (2011) Binding preferences for GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells. Arterioscler. Thromb. Vasc. Biol. 31, 176-182
32. Sonnenburg, W. K., Yu, D., Lee, E.-C., Xiong, W., Gololobov, G., Key, B., Gay, J., Wilganowski, N., Hu, Y., Zhao, S., Schneider, M., Ding, Z.-M., Zambrowicz, B. P., Landes, G., Powell, D. R., and Desai, U. (2009) GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4. J. Lipid Res. 50, 2421-2429
33. Lafferty, M. J., Bradford, K. C., Erie, D. A., and Neher, S. B. (2013) Angiopoietin-like protein 4 inhibition of lipoprotein lipase: evidence for reversible complex formation. J. Biol. Chem. 288, 28524-28534
34. Ge, H., Yang, G., Huang, L., Motola, D. L., Pourbahrami, T., and Li, C. (2004) Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4. J. Biol. Chem. 279, 2038-2045
35. Chomel, C., Cazes, A., Faye, C., Bignon, M., Gomez, E., Ardidie-Robouant, C., Barret, A., Ricard-Blum, S., Muller, L., Germain, S., and Monnot, C. (2009) Interaction of the coiled-coil domain with glycosaminoglycans protects angiopoietin-like 4 from proteolysis and regulates its antiangiogenic activity. FASEB J. 23, 940-949
36. Yin, W., Romeo, S., Chang, S., Grishin, N. V., Hobbs, H. H., and Cohen, J. C. (2009) Genetic variation in ANGPTL4 provides insights into protein processing and function. J. Biol. Chem. 284, 13213-13222
37. Lei, X., Shi, F., Basu, D., Huq, A., Routhier, S., Day, R., and Jin, W. (2011) Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity. J. Biol. Chem. 286, 15747-15756
38. Ge, H., Cha, J.-Y., Gopal, H., Harp, C., Yu, X., Repa, J. J., and Li, C. (2005) Differential regulation and properties of angiopoietin-like proteins 3 and 4. J. Lipid Res. 46, 1484-1490
39. Nilsson, S. K., Anderson, F., Ericsson, M., Larsson, M., Makoveichuk, E., Lookene, A., Heeren, J., and Olivecrona, G. (2012) Triacylglycerol-rich lipoproteins protect lipoprotein lipase from inactivation by ANGPTL3 and ANGPTL4. Biochim. Biophys. Acta 1821, 1370-1378
40. Mandard, S., Zandbergen, F., Tan, N. S., Escher, P., Patsouris, D., Koenig, W., Kleemann, R., Bakker, A., Veenman, F., Wahli, W., Müller, M., and Kersten, S. (2004) The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J. Biol. Chem. 279, 34411-34420
41. Cazes, A., Galaup, A., Chomel, C., Bignon, M., Bréchot, N., Le Jan, S., Weber, H., Corvol, P., Muller, L., Germain, S., and Monnot, C. (2006) Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton. Circ. Res. 99, 1207-1215
42. Merkel, M., Kako, Y., Radner, H., Cho, I. S., Ramasamy, R., Brunzell, J. D., Goldberg, I. J., and Breslow, J. L. (1998) Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: direct evidence that lipoprotein lipase bridging occurs in vivo. Proc. Natl. Acad. Sci. U.S.A. 95, 13841-13846
43. Merkel, M., Heeren, J., Dudeck, W., Rinninger, F., Radner, H., Breslow, J. L., Goldberg, I. J., Zechner, R., and Greten, H. (2002) Inactive lipoprotein lipase (LPL) alone increases selective cholesterol ester uptake in vivo, whereas in the presence of active LPL it also increases triglyceride hydrolysis and whole particle lipoprotein uptake. J. Biol. Chem. 277, 7405-7411
44. Olivecrona, G., and Olivecrona, T. (1995) Triglyceride lipases and atherosclerosis. Curr. Opin. Lipidol. 6, 291-305
45. Yoshida, K., Shimizugawa, T., Ono, M., and Furukawa, H. (2002) Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J. Lipid Res. 43, 1770-1772
46. Smart-Halajko, M. C., Robciuc, M. R., Cooper, J. A., Jauhiainen, M., Kumari, M., Kivimaki, M., Khaw, K.-T., Boekholdt, S. M., Wareham, N. J., Gaunt, T. R., Day, I. N., Braund, P. S., Nelson, C. P., Hall, A. S., Samani, N. J., et al. (2010) The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk. Arterioscler. Thromb. Vasc. Biol. 30, 2277-2282
47. Robciuc, M. R., Tahvanainen, E., Jauhiainen, M., and Ehnholm, C. (2010) Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample. J. Lipid Res. 51, 824-831
48. Mehta, N., Qamar, A., Qu, L., Qasim, A. N., Mehta, N. N., Reilly, M. P., and Rader, D. J. (2014) Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits. Arterioscler. Thromb. Vasc. Biol. 34, 1057-1063
49. Adhikary, T., Brandt, D. T., Kaddatz, K., Stockert, J., Naruhn, S., Meissner, W., Finkernagel, F., Obert, J., Lieber, S., Scharfe, M., Jarek, M., Toth, P. M., Scheer, F., Diederich, W. E., Reinartz, S., et al. (2013) Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion. Oncogene 32, 5241-5252
50. Jonker, J. T., Smit, J. W., Hammer, S., Snel, M., van der Meer, R. W., Lamb, H. J., Mattijssen, F., Mudde, K., Jazet, I. M., Dekkers, O. M., de Roos, A., Romijn, J. A., Kersten, S., and Rensen, P. C. (2013) Dietary modulation of plasma angiopoietin-like protein 4 concentrations in healthy volunteers and in patients with type 2 diabetes. Am. J. Clin. Nutr. 97, 255-260